Back to Prevention

What Is Cabotegravir and What Is It For?

What Is Cabotegravir and What Is It For?
Bareback Guide 17 July 2026

Cabotegravir is an integrase strand transfer inhibitor formulated as a long-acting injectable suspension. It changed HIV care by making it possible to be treated or protected without taking anything daily.

What kind of drug is it?

An integrase inhibitor, the newest of the main antiretroviral classes and the one that now dominates HIV treatment. It is closely related to dolutegravir, sharing the same mechanism and much of the same molecular structure.

How does it work?

To establish an infection, HIV must insert a DNA copy of its genome into the chromosomes of the cell it has entered, using an enzyme called integrase. Cabotegravir binds to that enzyme and blocks the strand transfer step, the point at which the insertion actually happens.

What happens if integration is blocked?

The viral DNA remains loose in the cell, unable to direct the production of new virus, and is eventually degraded. The infection does not become established in that cell. Because integration is an essential and irreversible step, blocking it is an effective place to intervene.

Why can it be given every two months?

Because the injectable form is a suspension of drug crystals rather than a solution. Injected into muscle, the crystals dissolve slowly over weeks, releasing drug continuously. This is a formulation achievement rather than a property of the molecule itself.

What is it used for in treatment?

For people already virally suppressed who would prefer injections to daily tablets. It is given with long-acting rilpivirine as a pair of injections at the same appointment. It is not used to start treatment in someone with a detectable viral load.

What is it used for in prevention?

As long-acting PrEP for people who are HIV negative. Availability in the UK has been developing and differs by area, so your clinic is the place to ask what is currently commissioned locally rather than assuming either way.

Why does an oral form exist?

As a lead-in to check tolerability before committing to an injection that cannot be removed, and as a bridge if an injection has to be delayed. The oral lead-in is not always required and practice has moved towards starting with the injection in many cases.

Why is it given with rilpivirine for treatment?

Because HIV treatment requires more than one active drug to prevent resistance. Rilpivirine, a non-nucleoside, is the other long-acting injectable available, so the pair provides two-drug therapy in injectable form.

Why is it used alone for prevention?

Because prevention has a different requirement: there is no established infection to suppress, only exposure to block. Single-agent PrEP is standard, and the important corollary is that HIV testing before every injection is essential, since giving one drug to someone already infected risks resistance.

How does it compare with daily tablets?

Trials found injectable PrEP more effective than daily oral PrEP, with the difference driven almost entirely by adherence rather than by the drug being intrinsically superior. For anyone who struggles with daily dosing, that difference is substantial.

Who is it suited to?

People for whom daily tablets are the obstacle rather than the medicine: those who find the daily reminder difficult, who travel unpredictably, who share living space where privacy is limited, or who simply prefer it. Trial participants consistently preferred injections to tablets.

Does it prevent anything else?

No. It covers HIV only, with no activity against hepatitis B or anything else transmitted sexually. Regular three-monthly screening at every site remains necessary and needs arranging separately from the two-monthly injection.

Where does it sit against the alternatives?

No antiretroviral is best in every situation. What matters is the fit between the drug and your kidney function, your other medicines, your hepatitis status, your resistance history and how you actually live. That is a conversation with a clinician rather than a ranking.

Is it available in the UK?

Availability and how services provide it change, and commissioning differs between the four nations and between local areas. Your clinic is the reliable source for what you can actually get, rather than what exists in principle.